Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Neoplasms × Drug Therapy × Clear all

Sponsor

Conditions

Breast Neoplasms 14 Carcinoma, Non-Small-Cell Lung 13 Neoplasms 10 Head and Neck Neoplasms 8 Carcinoma, Squamous Cell 8 Lung Neoplasms 7 Leukemia, Myeloid, Acute 7 Glioblastoma 7 Colorectal Neoplasms 7 Ovarian Neoplasms 6 Neoplasm Metastasis 6 Recurrence 5 Pancreatic Neoplasms 5 Melanoma 5 Leukemia 5 Prostatic Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Non-Hodgkin 4 Fallopian Tube Neoplasms 4 Anemia, Refractory, with Excess of Blasts 4 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Rectal Neoplasms 3 Lymphoma, Follicular 3 Colonic Neoplasms 3 Brain Neoplasms 3 Treatment 2 Sarcoma 2 Pleural Effusion, Malignant 2 Pharyngeal Neoplasms 2

Interventions

vandetanib 7 Sorafenib 6 Magnetic Resonance Spectroscopy 6 lenvatinib 5 cabozantinib 5 Sunitinib 4 Iodine-131 4 selpercatinib 3 AZD 6244 3 trametinib 2 tipifarnib 2 durvalumab 2 dabrafenib 2 alectinib 2 Triiodothyronine 2 Thyroxine 2 Thyrotropin Alfa 2 Paclitaxel 2 Nivolumab 2 Ipilimumab 2 Fluorodeoxyglucose F18 2 Everolimus 2 Bortezomib 2 Axitinib 2 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2 tremelimumab 1 temsirolimus 1 tanespimycin 1 sapanisertib 1 romidepsin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡